Dermatomyositis pattern
Does This Rash Suggest Dermatomyositis or Systemic Disease?
A concise clinician guide for Gottron lesions, heliotrope rash, shawl/V-sign, weakness, dysphagia, and systemic disease clues.
Quick answer
Systemic Rash Pattern
- Derm discussion is reasonable when morphology suggests dermatomyositis or another systemic autoimmune disease and skin findings may guide biopsy, Rheum/oncology direction, or immunosuppression decisions.
- Ask about weakness, dysphagia, dyspnea/ILD symptoms, arthritis, Raynaud, oral ulcers, and malignancy history.
- Rheum, neurology, oncology, or medicine may be concurrent depending on the systemic syndrome.
Derm discussion is reasonable when
Higher-Yield Consult Context
- Gottron papules/sign, heliotrope rash, shawl/V-sign, holster sign, nailfold changes, photosensitive poikiloderma, or other dermatomyositis pattern.
- Weakness, dysphagia, dyspnea/ILD symptoms, systemic symptoms, or malignancy concern is present.
- Biopsy or morphology would change Rheum, oncology, neurology, medicine, or immunosuppression direction.
Workup or other service first when
Better First Step
- The immediate concern is infection, sepsis, or another emergency that should be stabilized first.
- Stable chronic rash without systemic features or inpatient decision impact may be outpatient.
- Rheum or medicine may be the main service when systemic disease management is already clear.
Common pitfall
Keep the Question Specific
The value is not simply naming a rash. The value is whether skin findings change systemic workup, biopsy, malignancy concern, or immunosuppression decisions.
FAQ
Clinician Questions
What features suggest dermatomyositis?
Gottron papules/sign, heliotrope rash, shawl/V-sign, holster sign, nailfold changes, and photosensitive poikiloderma can be relevant patterns. *
What systemic symptoms matter?
Weakness, dysphagia, dyspnea/ILD symptoms, arthritis, Raynaud, fever, weight loss, and malignancy history.
Who else may need involvement?
Rheum, neurology, oncology, medicine, and pulmonary may be relevant depending on weakness, ILD, malignancy concern, and inpatient acuity.
References
Educational tool only. SIC provides clinician-facing educational consult-triage references. SIC does not diagnose, treat, prevent, cure, or mitigate disease and is not a substitute for clinical judgment, local guidelines, institutional referral pathways, or recommendations from your dermatology department. See disclaimer.